Timothy P. Coleman
Ph.D. MBA CEO and President
Chairman of the Board
Tim has been in the industry for 15+ years and was recently a manager in the healthcare advisory practice at PricewaterhouseCoopers. Prior to joining PwC, Dr. Coleman was president,
CEO and co-founder of BioCache Pharmaceuticals, Inc., a Richmond, Virginia-based biopharmaceutical company primarily engaged in the research and development of cancer vaccines.
There, he was a National Cancer Institute funded principal investigator studying the interaction of cancer vaccines with Toll-Like Receptors (TLRs) to induce a clinically
relevant immune response. Additionally, he successfully led the firm’s growth through early stage funding, strategic expansion and eventual establishment of a non-founding
executive leadership team.